DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Requip (Ropinirole) - Adverse Event Reports - Hospitalization - Dyspnoea

 



Index of reports > Cases resulting in hospitalization (91) > Cases with Dyspnoea (12)

Below is the selection of adverse event reports related to Requip (Ropinirole) that includes cases resulting in hospitalization where reactions include dyspnoea.

Adverse event in 64 year old male receiving Requip (Ropinirole)

Reported by a physician from United States on 2007-10-09

Patient: 64 year old male, weighing 109.8 kg (241.5 pounds)

Adverse reactions / side effects: Dyspnoea, Chest Pain, Atrial Fibrillation, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Requip (Ropinirole)



Adverse event in 73 year old male receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-06-15

Patient: 73 year old male

Adverse reactions / side effects: Dyspnoea, Dyspnoea Exertional, Interstitial Lung Disease

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Suspect drug(s):
Requip (Ropinirole)

Other drugs received by patient: Heart Medication



Adverse event in 73 year old male receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: 73 year old male

Adverse reactions / side effects: Dyspnoea, Dyspnoea Exertional, Interstitial Lung Disease

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Suspect drug(s):
Requip (Ropinirole)

Other drugs received by patient: Heart Medication



Adverse event in 50 year old female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-05-11

Patient: 50 year old female

Adverse reactions / side effects: Neuropathy, Dyspnoea, Pain in Extremity, Insomnia, Oedema Peripheral, Muscular Weakness, Musculoskeletal Stiffness

Adverse event resulted in: hospitalization

Suspect drug(s):
Requip (Ropinirole)

Other drugs received by patient: Estrogen Replacement; Levothyroxine Sodium; Lasix



Adverse event in 56 year old female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-05-04

Patient: 56 year old female

Adverse reactions / side effects: Weight Decreased, Dysphagia, Dyspnoea, Pain, Somnolence, Loss of Consciousness, Pulse Pressure Increased, Syncope, Palpitations, Insomnia, Ecchymosis, Musculoskeletal Stiffness

Adverse event resulted in: hospitalization

Suspect drug(s):
Sinemet
    Dosage: 12.5 + 125mg/qid 10-oct-2006-25-mar-2007; reduced to 12.5 + 125mf bid on 26-march-2007
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2006-10-10
    End date: 2007-03-25

Requip
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2007-01-01

Other drugs received by patient: Ropinirole HCL; Evista; Inderal



Adverse event in female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional on 2007-05-02

Patient: female, weighing 85.0 kg (187.0 pounds)

Adverse reactions / side effects: Intercostal Neuralgia, Drug Effect Decreased, Dyspnoea, Magnesium Deficiency, Muscular Weakness, Hyperuricaemia, Hypercholesterolaemia, Anxiety, Spinal Osteoarthritis, Thyroid Neoplasm, Feeling Abnormal, Intervertebral Disc Displacement

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Sifrol
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2005-07-01
    End date: 2006-03-01

Sifrol
    Indication: Extrapyramidal Disorder

Madopar LT
    Dosage: 400-500 mg levodopa/benserazide
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2003-08-01
    End date: 2004-01-01

Restex Retard
    Dosage: at night
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2003-08-01
    End date: 2004-01-01

Madopar LT
    Dosage: 200 mg levodopa/benserazide
    Administration route: Oral
    Start date: 2004-01-01
    End date: 2005-01-01

Valoron
    Dosage: at night
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2004-01-01
    End date: 2005-01-01

Requip
    Administration route: Oral
    Indication: Restless Legs Syndrome
    Start date: 2005-02-01
    End date: 2005-06-01

Other drugs received by patient: Magnerot Classic; Valoron; Ceferro



Adverse event in female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-04-23

Patient: female

Adverse reactions / side effects: Vomiting, Dyspnoea, Retching, Crohn's Disease, Fall, Loss of Consciousness, Anxiety, Malaise, Chest Pain, Dizziness, Toothache, Sensitivity of Teeth, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Requip (Ropinirole)

Other drugs received by patient: Entocort; Protonix; Synthroid; Boniva; Clonazepam



Adverse event in 69 year old male receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from France on 2007-03-26

Patient: 69 year old male

Adverse reactions / side effects: Dyspnoea, Anaemia, Neutropenia, Purpura, Melaena, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Requip
    Dosage: 1tab three times per day
    Administration route: Oral
    Indication: Parkinson's Disease

Cordarone
    Dosage: 1tab per day
    Administration route: Oral
    Start date: 2007-02-01
    End date: 2007-02-22

Lasix
    Dosage: 20mg per day
    Administration route: Oral
    Start date: 2006-12-15
    End date: 2007-02-22

Modopar
    Administration route: Oral
    Indication: Parkinson's Disease

Sinemet
    Dosage: 50mg twice per day
    Administration route: Oral
    Indication: Parkinson's Disease

Ketoprofen
    Administration route: Oral
    Start date: 2007-02-10
    End date: 2007-02-22

Atacand
    Dosage: 8mg per day
    Administration route: Oral
    Start date: 2006-12-15
    End date: 2007-02-22

Stalevo 100
    Dosage: 1tab three times per day
    Administration route: Oral
    Indication: Parkinson's Disease

Other drugs received by patient: Burinex



Adverse event in female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-02-15

Patient: female

Adverse reactions / side effects: Vomiting, Dyspnoea, Retching, Crohn's Disease, Fall, Loss of Consciousness, Malaise, Chest Pain, Dizziness, Toothache, Sensitivity of Teeth, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Requip (Ropinirole)

Other drugs received by patient: Entocort; Protonix; Synthroid; Boniva; Clonazepam



Adverse event in female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-02-07

Patient: female

Adverse reactions / side effects: Vomiting, Dyspnoea, Crohn's Disease, Malaise, Chest Pain, Dizziness, Toothache, Asthenia, Sensitivity of Teeth

Adverse event resulted in: hospitalization

Suspect drug(s):
Requip (Ropinirole)



Adverse event in female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-01-25

Patient: female

Adverse reactions / side effects: Vomiting, Dyspnoea, Crohn's Disease, Malaise, Chest Pain, Dizziness, Toothache, Asthenia, Sensitivity of Teeth

Adverse event resulted in: hospitalization

Suspect drug(s):
Requip (Ropinirole)



Adverse event in female receiving Requip (Ropinirole)

Reported by a consumer/non-health professional from United States on 2007-01-16

Patient: female

Adverse reactions / side effects: Vomiting, Dyspnoea, Crohn's Disease, Malaise, Chest Pain, Dizziness, Toothache, Asthenia, Sensitivity of Teeth

Adverse event resulted in: hospitalization

Suspect drug(s):
Requip (Ropinirole)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009